BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11363958)

  • 1. Human subject protection in clinical trials.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):19-23. PubMed ID: 11363958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
    Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of human subjects: categories of research that may be reviewed by the Institutional Review Board (IRB) through an expedited review procedure--FDA. Notice.
    Fed Regist; 1998 Nov; 63(216 Pt 1):60353-6. PubMed ID: 10187395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
    Nightingale SL
    J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Researcher liability for negligence in human subject research: informed consent and researcher malpractice actions.
    Jansson RL
    Wash Law Rev; 2003 Feb; 78(1):229-63. PubMed ID: 15732212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical and institutional review board issues.
    Skolnick BE
    Adv Neurol; 1998; 76():253-62. PubMed ID: 9408484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    Fed Regist; 1978 Nov; 43(231):56173-98. PubMed ID: 10239683
    [No Abstract]   [Full Text] [Related]  

  • 10. Human subject protections in the United States: perspectives from the Office for Protection from Research Risks.
    Russell-Einhorn M; Ellis GB
    J Biolaw Bus; 1998; 1(2):36-8. PubMed ID: 12739540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug regulation and policy formulation.
    Nightingale SL
    Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FDA's role in medical device clinical studies of human subjects.
    Saviola J
    J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
    Cohen J;
    AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health and Human Services policy for protection of human subjects research--HHS. Final rule.
    Fed Regist; 1994 Jun; 59(104):28276. PubMed ID: 10135123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of human subjects; reports of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research--Office of the Assistant Secretary for Health, HHS. Notice of availability of reports.
    Fed Regist; 1983 Jul; 48(146):34408-12. PubMed ID: 10261488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical and legal issues in emergency research: barriers to conducting prospective randomized trials in an emergency setting.
    Morrison CA; Horwitz IB; Carrick MM
    J Surg Res; 2009 Nov; 157(1):115-22. PubMed ID: 19765724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in human subject protection.
    Nightingale SL
    Food Drug Law J; 1995; 50(4):493-501. PubMed ID: 10343016
    [No Abstract]   [Full Text] [Related]  

  • 19. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
    Klitzman R
    Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research in the hospital setting on human subjects. Protecting the patient and the institution.
    Scheuer R
    Mt Sinai J Med; 1993 Oct; 60(5):391-8. PubMed ID: 8259119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.